Heska Corporation (NASDAQ: HSKA) sells advanced veterinary diagnostic and other specialty veterinary products. Heska's state-of-the-art offerings to its customers include blood testing instruments and supplies, digital imaging products, software and services, and single use products and services such as in-clinic heartworm diagnostic tests, heartworm preventive products, allergy immunotherapy products and allergy testing. The Company's core focus is on the canine and feline markets where it strives to provide high value products and unparalleled customer support to veterinarians.
Q2 2015 Earnings Call
B. Riley & Co. Investor Conference – May 13, 2015 Link
B. Riley & Co. Investor Conference – May 13, 2015 Presentation
Independent Registered Public Accountant: EKS&H LLLP, Boulder, Colorado
Transfer Agent: Computershare Trust Company, Golden, Colorado
Stock Listing Symbol: HSKA
Stock Exchange: NASDAQ Capital Market
Investor Relations Contact Information
attn: Investor Relations
3760 Rocky Mountain Ave
Loveland, CO 80538
Phone: (970) 493-7272
Fax: (970) 619-3003
2014 Heska Corporation Annual Report
The following link will take you to the SEC's EDGAR search page containing all Heska filings. When you are done finding the documents you are looking for, simply close the SEC window to return here.
ALL SEC filings from January 1st, 2001 - present
Extensible Business Reporting Language (XBRL)
XBRL is an XML-based language for the electronic transmission of business and financial data. XBRL is not an accounting standard; it is simply a standard for transmitting business and financial data.
The various XBRL exhibits included on this web page are displayed in their native XML format and have been included to provide you the option of importing them into your XBRL viewer of choice.